Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 0.61 |
| ▸ | ITGAV | P06756 | 20/20 | 0.61 |
| ▸ | ITGA2B | P08514 | 17/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6016422 | 0.93 | ITGB3 (0.60) | ITGB3ITGAVITGA2B | |
| SCHEMBL6016149 | 0.91 | ITGB3 (0.60) | ITGB3ITGAVITGA2B | |
| SCHEMBL3366589 | 0.87 | ITGB3 (0.45) | ITGB3ITGAVITGA2B | |
| Hydrochloric Acid SCHEMBL3366043 | 0.86 | ITGB3 (0.44) | ITGB3ITGAVITGA2B | |
| Acetic Acid SCHEMBL3369125 | 0.85 | ITGB3 (0.45) | ITGB3ITGAVITGA2B | |
| SCHEMBL6016329 | 0.82 | ITGB3 (0.85) | ITGB3ITGAVITGA2B | |
| SCHEMBL6016326 | 0.82 | ITGB3 (0.85) | ITGB3ITGAVITGA2B | |
| SCHEMBL6016254 | 0.76 | ITGB3 (0.61) | ITGB3ITGAVITGA2B | |
| SCHEMBL6016423 | 0.76 | ITGB3 (0.84) | ITGB3ITGAVITGA2B | |
| SCHEMBL6016177 | 0.76 | ITGB3 (1.00) | ITGB3ITGAVITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1086098-B1 | THIENYL SUBSTITUTED ACYLGUANIDINES AS INHIBITORS OF BONE RESORPTION AND VITRONECTIN RECEPTOR ANTAGONISTS | AVENTIS PHARMA GMBH (DE) | 2006-04-05 | — | — | EP | disclosed |
| US-6660728-B2 | Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-12-09 | — | — | US | disclosed |
| US-6566366-B1 | For therapy of tumor growth, osteoporosis, inflammation and cardiovascular disorders | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-05-20 | — | — | US | disclosed |
| EP-1086098-A1 | THIENYL SUBSTITUTED ACYLGUANIDINES AS INHIBITORS OF BONE RESORPTION AND VITRONECTIN RECEPTOR ANTAGONISTS | Aventis Pharma Deutschland GmbH (DE) | 2001-03-28 | — | — | EP | disclosed |
| EP-0960882-A1 | Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists | Hoechst Marion Roussel Deutschland GmbH (DE) | 1999-12-01 | — | — | EP | disclosed |
| WO-1999059992-A1 | THIENYL SUBSTITUTED ACYLGUANIDINES AS INHIBITORS OF BONE RESORPTION AND VITRONECTIN RECEPTOR ANTAGONISTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 1999-11-25 | — | — | WO | disclosed |